XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,038,000) $ (13,986,000)
Adjustments to reconcile net loss to cash used in operating activities:    
Change in fair value of common stock warrant and option liabilities 1,474,000 (6,544,000)
Issuance and offering costs allocated to liability classified options 0 430,000
Valuation loss on March 2023 PIPE 0 6,076,000
Depreciation 113,000 287,000
Lease amortization 652,000 697,000
Amortization of note receivable discount (157,000) 0
Gain on disposal of property and equipment (65,000) (40,000)
Gain on sale of collaborative arrangements (4,000,000) 0
Stock-based compensation 512,000 717,000
Bad debt expense 0 20,000
Write-down of inventories 154,000 444,000
Impairment of property and equipment 36,000 0
Impairment of ROU asset 0 113,000
Write-down of non-controlling interest 138,000 0
Changes in operating assets and liabilities:    
Accounts receivable and other receivables (762,000) 184,000
Inventories 550,000 (2,419,000)
Prepaid expenses and other current assets (124,000) 1,000
Other noncurrent assets 72,000 2,000
Accounts payable and accrued expenses (303,000) (522,000)
Amounts due to related parties (29,000) 10,000
Operating lease payments (850,000) (764,000)
Net cash used in operating activities (9,627,000) (15,294,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of property and equipment 334,000 115,000
Proceeds from sale of Verdeca - earn-out received 0 569,000
Proceeds from sale of investments 5,024,000 2,502,000
Proceeds from sale of RS durum wheat trait 4,000,000 0
Cash paid related to sale of GoodWheat (2,000,000) 0
Purchases of property and equipment (16,000) (5,000)
Purchases of investments 0 (7,525,000)
Net cash provided by (used in) investing activities 7,342,000 (4,344,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from ESPP purchases 9,000 12,000
Net cash provided by financing activities 9,000 5,512,000
Net decrease in cash and cash equivalents (2,276,000) (14,126,000)
Cash and cash equivalents - beginning of period 6,518,000 20,644,000
Cash and cash equivalents - end of period 4,242,000 6,518,000
NONCASH TRANSACTIONS:    
Proceeds from sale of property and equipment in accounts receivable and other receivables 0 8,000
Right of use assets obtained in exchange for new operating lease liabilities 86,000 0
Note receivable recognized from sale of GoodWheat 5,705,000 0
March 2023 PIPE [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock, pre-funded warrants and preferred investment options from March 2023 PIPE 0 5,997,000
Payments of offering costs relating to March 2023 PIPE 0 (497,000)
NONCASH TRANSACTIONS:    
Common stock options issued to placement agent and included in offering costs 0 212,000
Warrant and option modifications included in Valuation loss on March 2023 PIPE $ 0 $ 404,000